Your browser doesn't support javascript.
loading
H19 Is Expressed in Hybrid Hepatocyte Nuclear Factor 4α+ Periportal Hepatocytes but Not Cytokeratin 19+ Cholangiocytes in Cholestatic Livers.
Jiang, YanChao; Huang, Yi; Cai, ShiYing; Song, YongFeng; Boyer, James L; Zhang, KeZhong; Gao, Ling; Zhao, JiaJun; Huang, WenDong; Liang, Guang; Liangpunsakul, Suthat; Wang, Li.
Afiliação
  • Jiang Y; Department of Physiology and Neurobiology and the Institute of Systems Genomics University of Connecticut Storrs CT.
  • Huang Y; Department of Physiology and Neurobiology and the Institute of Systems Genomics University of Connecticut Storrs CT.
  • Cai S; School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou China.
  • Song Y; Department of Internal Medicine, Liver Center Yale University New Haven CT.
  • Boyer JL; Department of Physiology and Neurobiology and the Institute of Systems Genomics University of Connecticut Storrs CT.
  • Zhang K; Department of Endocrinology and Metabolism Shandong Provincial Hospital/Shandong University Jinan China.
  • Gao L; Department of Internal Medicine, Liver Center Yale University New Haven CT.
  • Zhao J; Center for Molecular Medicine and Genetics Wayne State University School of Medicine Detroit MI.
  • Huang W; Department of Endocrinology and Metabolism Shandong Provincial Hospital/Shandong University Jinan China.
  • Liang G; Department of Endocrinology and Metabolism Shandong Provincial Hospital/Shandong University Jinan China.
  • Liangpunsakul S; Department of Diabetes Complications and Metabolism, Diabetes and Metabolism Research Institute Beckman Research Institute, City of Hope National Medical Center Duarte CA.
  • Wang L; School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou China.
Hepatol Commun ; 2(11): 1356-1368, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30411082
ABSTRACT
Long noncoding RNA (lncRNA) H19 is abundantly expressed in fetal liver. Its expression is significantly diminished in adult healthy liver but is re-induced in chronic liver diseases, including cholestasis. In this study, we developed a new method with combined in situ hybridization (ISH) and immunofluorescence (IF) colabeling to establish an H19 expression profile with both parenchymal and nonparenchymal cell-specific markers in the livers of cholestatic mouse models and patients with cholestasis. H19RNA+ cells showed no colocalization with biliary epithelial cell marker cytokeratin 19 (CK19)+ cholangiocytes but were immediately adjacent to biliary structures in bile duct ligation (BDL), 3,5-diethoxycarbony1-1,4-dihydrocollidine (DDC), and multidrug-resistant gene 2 knockout ( Mdr2 -/- ) mouse models and in human primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) liver specimens. In contrast, double-positive H19RNA+/sex-determining region Y (SRY)-box 9 (SOX9)+ ductal progenitor cells, H19RNA+/hepatocyte nuclear factor 4α (HNF4α)+ hepatocytes, H19RNA+/F4/80+ Kupffer cells, HNF4α+/SOX9+ hybrid hepatocytes, as well as triple-positive H19 RNA+/HNF4α+/SOX9+ periportal hepatocytes were identified. In addition, H19 RNA could not be detected in mesenchymal cell marker desmin+ cells. Furthermore, H19 RNA was predominately detected in cytoplasm with a small amount at the interspace with neighboring cells.

Conclusion:

H19RNA is localized in HNF4α+ periportal hepatocytes, SOX9+ ductal progenitor cells, and F4/80+ Kupffer cells but not in CK19+ cholangiocytes and desmin+ stellate cells in cholestatic livers.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article